Form 4: Precision BioSciences CEO Michael Amoroso Reports Acquisition of Restricted Stock Units
SEC Form 4 Filing
Michael Amoroso, CEO of Precision BioSciences, reports the acquisition of 111,217 restricted stock units.
Summary
- Michael Amoroso, the President and CEO of Precision BioSciences, reported a transaction on April 18, 2024.
- He acquired 111,217 restricted stock units, each representing a contingent right to receive one share of Precision BioSciences' common stock.
- The award vests in three substantially equal annual installments starting on January 20, 2025, contingent upon Amoroso's continued service to the Issuer.
Sentiment
Score: 6
Explanation: The document is a routine regulatory filing. The acquisition of restricted stock units is generally viewed as a positive sign, aligning management's interests with shareholders, but it's not a major event.
Positives
- The acquisition of restricted stock units by the CEO aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the CEO.
Future Outlook
The vesting of the restricted stock units is contingent upon the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- Shareholders may view the acquisition of restricted stock units by the CEO as a positive sign, aligning his interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 04/18/2024 | Date of transaction: Acquisition of restricted stock units. |
| 01/20/2025 | First vesting date for the restricted stock units. |
| 04/22/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.